Association of treponemal chemiluminescent immunoassay signal intensity with TPPA reactivity in reverse sequence syphilis screening

ABSTRACT Reverse sequence screening for syphilis using treponemal chemiluminescent immunoassays (Tp-CIAs) is widely used in clinical laboratories; however, interpretation is typically based on binary cutoff values, and the clinical value of signal intensity remains underutilized. We conducted a retrospective diagnostic performance accuracy study including 1,827 individuals undergoing routine screening to evaluate the clinical utility of the Tp-CIA cutoff index (COI) as a continuous variable, using the TPPA as the reference standard. ROC analysis was performed to determine the optimal cutoff, and associations between COI values and TPPA reactivity were assessed. Tp-CIA demonstrated excellent discrimination of TPPA reactivity (area under the curve 0.992). COI values showed a strong monotonic association with TPPA reactivity (Spearman r s = 0.855), increasing from 2.5% at a COI <1 to 99.8% at a COI ≥30. An exploratory cutoff of COI = 3.25 increased specificity from 88.6% to 96.4%, with a corresponding decrease in sensitivity from 99.1% to 95.9%, compared with the manufacturer-recommended cutoff of 1.0. Discordant results (3.9%) were largely confined to low COI values, whereas high COI values were strongly associated with TPPA reactivity. Diagnostic performance remained consistent across HIV subgroups. Among individuals with concurrent non-treponemal testing, COI values were positively correlated with ordered rapid plasma reagin ( r s = 0.637) and toluidine red unheated serum test ( r s = 0.705) titer levels. These findings demonstrate that, within the analytical conditions of this study, higher assay-specific COI values were associated with a greater likelihood of TPPA reactivity. COI-based interpretation should remain supplementary to established confirmatory testing and clinical assessment; exploratory threshold requires independent analytical and clinical validation. IMPORTANCE Syphilis remains a growing global public health concern, and reverse sequence screening using Treponema pallidum chemiluminescent immunoassay (Tp-CIA) is widely adopted. Although these assays are interpreted qualitatively using manufacturer-defined cutoffs, the underlying signal intensity varies across specimens. In this study cohort, increasing Tp-CIA cutoff index (COI) values were associated with an increasing observed proportion of TPPA-reactive results. This association was assay- and cohort-specific and should be interpreted descriptively. COI should not replace established confirmatory testing, quantitative non-treponemal testing, or clinical assessment, and its potential supplementary value requires independent analytical and clinical validation.

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2026-11-17
DOI
https://doi.org/10.1128/spectrum.01501-26
Primary Topic
Syphilis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of treponemal chemiluminescent immunoassay signal intensity with TPPA reactivity in reverse sequence syphilis screening

Yanhua Yu, Jinli Lou, 田树萍, JIANG Feifei et al.
1 links
Microbiology Spectrum
Syphilis Diagnosis and Treatment
article

Association of treponemal chemiluminescent immunoassay signal intensity with TPPA reactivity in reverse sequence syphilis screening

Yanhua Yu, Jinli Lou, 田树萍, JIANG Feifei, Yu Li, 冯霞, Hui Liu, Yuhan Duan, Xin Liu, Shujing Huang
article en

Abstract

ABSTRACT Reverse sequence screening for syphilis using treponemal chemiluminescent immunoassays (Tp-CIAs) is widely used in clinical laboratories; however, interpretation is typically based on binary cutoff values, and the clinical value of signal intensity remains underutilized. We conducted a retrospective diagnostic performance accuracy study including 1,827 individuals undergoing routine screening to evaluate the clinical utility of the Tp-CIA cutoff index (COI) as a continuous variable, using the TPPA as the reference standard. ROC analysis was performed to determine the optimal cutoff, and associations between COI values and TPPA reactivity were assessed. Tp-CIA demonstrated excellent discrimination of TPPA reactivity (area under the curve 0.992). COI values showed a strong monotonic association with TPPA reactivity (Spearman r s = 0.855), increasing from 2.5% at a COI <1 to 99.8% at a COI ≥30. An exploratory cutoff of COI = 3.25 increased specificity from 88.6% to 96.4%, with a corresponding decrease in sensitivity from 99.1% to 95.9%, compared with the manufacturer-recommended cutoff of 1.0. Discordant results (3.9%) were largely confined to low COI values, whereas high COI values were strongly associated with TPPA reactivity. Diagnostic performance remained consistent across HIV subgroups. Among individuals with concurrent non-treponemal testing, COI values were positively correlated with ordered rapid plasma reagin ( r s = 0.637) and toluidine red unheated serum test ( r s = 0.705) titer levels. These findings demonstrate that, within the analytical conditions of this study, higher assay-specific COI values were associated with a greater likelihood of TPPA reactivity. COI-based interpretation should remain supplementary to established confirmatory testing and clinical assessment; exploratory threshold requires independent analytical and clinical validation. IMPORTANCE Syphilis remains a growing global public health concern, and reverse sequence screening using Treponema pallidum chemiluminescent immunoassay (Tp-CIA) is widely adopted. Although these assays are interpreted qualitatively using manufacturer-defined cutoffs, the underlying signal intensity varies across specimens. In this study cohort, increasing Tp-CIA cutoff index (COI) values were associated with an increasing observed proportion of TPPA-reactive results. This association was assay- and cohort-specific and should be interpreted descriptively. COI should not replace established confirmatory testing, quantitative non-treponemal testing, or clinical assessment, and its potential supplementary value requires independent analytical and clinical validation.

Microbiology Spectrum
Capital Medical University (CN), The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture (CN), Beijing YouAn Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Syphilis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon